K. Tryfonidis Et Al. , "A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)," EUROPEAN JOURNAL OF CANCER , vol.53, pp.144-154, 2016
Tryfonidis, K. Et Al. 2016. A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378). EUROPEAN JOURNAL OF CANCER , vol.53 , 144-154.
Tryfonidis, K., Basaran, G., Bogaerts, J., Debled, M., Dirix, L., Thery, J., ... Tjan-Heijnen, V. C. G.(2016). A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378). EUROPEAN JOURNAL OF CANCER , vol.53, 144-154.
Tryfonidis, Konstantinos Et Al. "A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)," EUROPEAN JOURNAL OF CANCER , vol.53, 144-154, 2016
Tryfonidis, Konstantinos Et Al. "A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)." EUROPEAN JOURNAL OF CANCER , vol.53, pp.144-154, 2016
Tryfonidis, K. Et Al. (2016) . "A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)." EUROPEAN JOURNAL OF CANCER , vol.53, pp.144-154.
@article{article, author={Konstantinos Tryfonidis Et Al. }, title={A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)}, journal={EUROPEAN JOURNAL OF CANCER}, year=2016, pages={144-154} }